Researchers analyze long-term benefit, safety of ICDs in patients with Brugada syndrome

Patients with Brugada syndrome (BrS) benefit from implantable cardioverter defibrillators (ICDs) but are at significant risk of device-related complications, according to the longest-term study to date on the topic.

Among 370 patients diagnosed with BrS at a single center, 104 were treated with ICDs. Researchers followed these individuals for a median of 9.3 years and published the results in the Journal of the American College of Cardiology.

Among their key findings:

  • 21 patients experienced a total of 81 appropriate shocks, an incidence rate of 2.2 per 100 person-years.
  • Patients who received an ICD for secondary prevention following resuscitated cardiac arrest or sustained ventricular arrhythmia were seven times more likely to experience an appropriate shock.
  • Of 45 patients who were asymptomatic at diagnosis, four (8.9 percent) received appropriate ICD therapy during follow-up. All four had a spontaneous type 1 electrocardiogram and inducible ventricular arrhythmias.
  • Nine patients experienced 37 inappropriate shocks, a rate of 0.9 per 100 person-years.
  • 20 percent of patients experienced other ICD-related complications.
  • One person died after an electrical storm during a lead extraction procedure.

The researchers pointed out Brugada syndrome (BrS) is often diagnosed in young, otherwise healthy individuals with a greater life expectancy than other conditions. Because ICDs are typically used for a longer period in this patient population, there is greater risk for device complications.

“Special care during ICD implantation, adequate device programming, and regular follow-up in a specialized cardiogenetic unit may allow reducing the number of adverse events,” wrote lead researcher Jaime Hernandez-Ojeda, MD, PhD, and colleagues.

""

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup